Needham Comments on CONMED (CNMD) Amid Sale Rumors
Tweet Send to a Friend
Needham analyst Mike Matson reiterated a Hold rating on CONMED (NYSE: CNMD).The analyst comments "After the market closed on 7/10/26 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


